Patent №
US 11,154,656
Granted
2021-10-26
Filed 2020
Owner
BETA BIONICS, INC.
Lab
—
AI components
3
planning · evo · hardware
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
17062436
An automated blood glucose control system can provide automatic delivery of glucose control therapy to a subject and receive information about manual glucose control therapy provided to the subject. The automated blood glucose control system can indicate an amount of a bolus of medicament via a control algorithm configured to control blood glucose level in the subject. The automated blood glucose control system can indicate an amount of a manual bolus of medicament, which can be used to model a diminishment of the medicament in the subject over time based at least in part on the manual bolus of medicament.
AI classification
Ownership
BETA BIONICS, INC.
assignment · 540110764
Assignors
EL-KHATIB, FIRAS H., DAMIANO, EDWARD R., RASKIN, EDWARD B., LIM, DAVID CHI-WAI, ROSINKO, MICHAEL J., COSTIK, JOHN R.
On an employer assignment, the assignors are typically the inventors.